GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Price-to-Operating-Cash-Flow
中文

Smith & Nephew (Smith & Nephew) Price-to-Operating-Cash-Flow : 17.66 (As of Apr. 25, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Smith & Nephew's share price is $24.57. Smith & Nephew's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39. Hence, Smith & Nephew's Price-to-Operating-Cash-Flow Ratio for today is 17.66.

The historical rank and industry rank for Smith & Nephew's Price-to-Operating-Cash-Flow or its related term are showing as below:

SNN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.85   Med: 16.99   Max: 29.88
Current: 17.76

During the past 13 years, Smith & Nephew's highest Price-to-Operating-Cash-Flow Ratio was 29.88. The lowest was 11.85. And the median was 16.99.

SNN's Price-to-Operating-Cash-Flow is ranked better than
57.53% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.61 vs SNN: 17.76

Smith & Nephew's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $1.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Smith & Nephew was 25.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -11.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -12.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -0.50% per year.

During the past 13 years, Smith & Nephew's highest 3-Year average Operating Cash Flow per Share Growth Rate was 43.00% per year. The lowest was -24.30% per year. And the median was 9.35% per year.


Smith & Nephew Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Smith & Nephew's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Price-to-Operating-Cash-Flow Chart

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.04 19.04 17.22 25.22 19.61

Smith & Nephew Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.22 - 25.22 - 19.61

Competitive Comparison of Smith & Nephew's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Smith & Nephew's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Price-to-Operating-Cash-Flow falls into.



Smith & Nephew Price-to-Operating-Cash-Flow Calculation

Smith & Nephew's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=24.57/1.391
=17.66

Smith & Nephew's Share Price of today is $24.57.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Smith & Nephew's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Smith & Nephew Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew (Smith & Nephew) Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022